The involvement of 5-HT in pain processing is both profound and perplexing. There exists both theoretical Fields and Basbaum, 1978) and clinical (Tollinson and Kriegel, 1988) evidence that, in the CNS, 5-HT inhibits spinal pain transmission. In the PNS, however, 5-HT appears to promote pain in migraine attacks (Fozard and Gray, 1989; Loisy et al., 1985) and in laboratory studies of human skin (Richardson and Engel, 1986) . Even studies restricted to the CNS show that spinally administered 5-HT can either inhibit (Wang, 1977; Jordan et al., 1978; Yaksh and Wilson, 1979; Davies and Roberts, 198 1; Hylden and Wilcox, 1983; Schmauss et al., 1983) or stimulate (Jordan et al., 1979; Fasmer et al., 1983; Hylden and Wilcox, 1983; Clatworthy et al., 1988; Vaught and Scott, 1988 ) nociceptive responses, depending on the dose and species tested. On the other hand, stimulation of raphe nuclei releases 5-HT in spinal cord dorsal horn (Yaksh and Tyce, 1979) and elicits inhibition of spinothalamic tract and other neurons (Belcher et al., 1978; Griersmith et al., 198 1; Johnston and Davies, 198 1) apparently by postsynaptic inhibition ofthese projection neurons (Giesler et al., 198 1) . Most traditional 5-HT antagonists have failed to block these descending inhibitory actions consistently or completely (Yezierski et al., 1982) . The existence of multiple receptors for 5-HT and the lack, until recently, of highly selective ligands for the appropriate receptors may have contributed to these contradictory findings.
In the last decade, at least three distinct 5-HT receptor subtypes have been identified. These subtypes are termed 5-HT,, 5-HT,, and 5-HT, receptors, with 5-HT, receptors further differentiated into A, B, C, and D subtypes (Pedigo et al., 198 1; Bradleyet al., 1986; Peroutka, 1986 Peroutka, , 1988 Fozard, 1987) . Studies with selective 5-HT, and 5-HT, ligands have done little to clarify the role of these subtypes in nociception since both proand antinociceptive effects can be produced by spinal administration ofagonists for either receptor subtype. 5-HT, receptors, probably of the B subtype, inhibit nociceptive neurons (El-Yassir et al., 1988) , but 5-HT,, receptor agonists promote nociception (Zemlan et al., 1983; Murphy and Zemlan, 1987; Alhaider et al., 1990) . Similarly, spinal 5-HT,, and/or 5-HT, receptors mediate both pronociceptive ) and antinociceptive effects (Solomon and Gebhart, 1988) .
The involvement of 5-HT, receptors in nociceptive processing has only recently been studied (Glaum et al., 1989,199O) . Unlike 5-HT, and 5-HT, receptors, which are coupled to G-proteins (Julius et al., 1988 (Julius et al., , 1990 Raymond et al., 1989) , 5-HT, receptors are ligand-gated cation channels (Derkach et al., 1989) and therefore should mediate neuronal excitation. 5-HT, receptors, thought to be located on the subcutaneous terminals of primary afferent sensory fibers, may mediate 5-HT-elicited pain in human dermis (Richardson and Engel, 1986) . Recent autoradiographical experiments indicate that there is a dense band of 5-HT, receptors in superficial dorsal horn where small-diameter primary afferent fibers terminate; the number of binding sites is greatly reduced by neonatal capsaicin treatment (Hamon et al., 1989) or dorsal rhizotomy @Porte et al., 199 l), suggesting that many are located on primary afferent fibers. However, the binding sites remaining after rhizotomy may be located on intrinsic CNS neurons in the dorsal horn; 5-HT, binding sites have been found on intrinsic neurons in other parts of the CNS (Kilpatrick et al., 1987) . Glaum et al. (1989 Glaum et al. ( , 1990 recently reported that in rats 5-HT-induced antinociception in the tailflick test is mediated by 5-HT, receptors. Our own behavioral studies are consistent with the involvement of 5-HT, receptors in spinal antinociception and suggest that they are located on intrinsic CNS neurons . We observed that 2-methyl5-HT (a selective 5-HT, agonist) effectively blocks scratching and biting behavior induced in mice by intrathecally administered substance P (SP) and NMDA, excitants that likely interact with intrinsic spinal neurons (Wilcox, 1988 (Wilcox, , 1991 Aanonsen et al., 1990 
Materials and Methods
Subjects and supplies. Subjects for the behavioral studies were 17-27-gm male Swiss-Webster-derived mice (Harlan Sprague+Dawley, Madison, WI) maintained in cages of no more than 10 mice per cage with free access to food and water in the University of Minnesota Research Animal Resources facilities for at least 24 hr before experimentation. Mice were used only once and were killed by exposure to CO,. Intrathecal injections in mice were carried out as previously reported (Hylden and Wilcox, 1980) . Subjects for the electrophysiological experiments were male Sprague-Dawley rats (375-500 gm) from the same supplier maintained in the same facility with no more than two rats per cage. Rats were used only once and were killed by overdose of pentobarbital or urethane (i.v.).
Substance P, N-methyl-n-aspartic acid (NMDA), 5aminovaleric acid hydrochloride (5-AVA), muscimol, picrotoxin, and (-)-bicuculline methiodide were purchased from Sigma Chemical Company (St. Louis, MO). 2-Methyl serotonin, (RS)-cr-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid HBr (AMPA), 3-tropanylindole-3-carboxylate , and phaclofen were purchased from Research Biochemical Inc. (Natick, MA). Zacopride and naloxone hydrochloride were kindly donated by A. H. Robins Co. (Richmond, VA) and Du Pont Pharmaceuticals (Wilmington, DE), respectively. Behavior. We first examined the antinociceptive effect of the selective 5-HT, agonist 2-methyl serotonin in mice using the radiant-heat tailflick test @'Amour and Smith, 194 1). The maximum allowable latency (cutoff) was set at 5 set; this was approximately three standard deviations above the control mean (2.4 set) for several initial groups of mice.This cutoff latency also served as a determinant of percent maximum possible antinociceptive effect (% MPE), which was calculated in the usual way as posttreatment latency minus control latency divided by cutoff minus control. Posttreatment latency was determined 5 min after intrathecal injection of the agonist (2-methyl serotonin) and antagonists (zacopride or ICS 205-930) or saline.
The tail-flick test does not allow differentiation between effects mediated by receptors located presynaptically on primary afferent fibers (i.e., presynaptic) and effects mediated by receptors located on intrinsic neurons in the spinal cord (i.e., postsynaptic). To examine the latter possibility, we used stimuli that purportedly act postsynaptically on spinal cord neurons (Wilcox, 199 1) . These stimuli include intrathecal injection of agonists that mimic the putative excitatory neurotransmitters glutamate and SP. Intrathecally administered NMDA (Aanonsen and Wilcox. 1987) and SP (Cridland and Hemv. 1986 ) elicit hvueraleesia and behavior similar to that observed after exposure to noxiouschemical stimuli (Hylden and Wilcox, 198 1; Hwang and Wilcox, 1986) . Although this is a convenient and informative test, the relevance of the biting and scratching behavior elicited by intrathecally applied SP to nociception has been challenged (Frenk et al., 1988) . On the other hand, the ability of most spinally active antinociceptive agents to inhibit this behavior (Wilcox, 1988) supports the utility of the test as an adjunct to thermal tests in studies of spinal antinociception.
Behaviors elicited by NMDA (biting; see Fig. 2A ) and SP (biting and scratching; see Fig. 2B ) were counted for 1 min following intrathecal administration.
2-Methyl serotonin was coadministered intrathecally with either excitant, and antagonists were given intrathecally as a pretreatment 5 min before. Both zacopride and ICS 205-930 were effective antagonists to 2-methyl serotonin, but we studied zacopride in most experiments because of its higher water solubility.
Statistics. Analysis of variance (ANOVA) with Dunnett's post hoc test was used to analyze the behavioral data and to test the difference between doses and antagonists. Tests of statistical significance with p < 0.01 were considered significant.
Electrophysiology. Extracellular recordings were conducted in spinal cord of male SpragusDawley rats anesthetized with urethane (1.2gm/ kg, i.p.), paralyzed with gallamine (27 mg/kg, i.v.), and artificially ventilated. Adequacy of anesthesia was established by continuous monitoring of heart rate and pupil diameter, and supplementary anesthesia (urethane, 50 mg/ml in 0.2~3.3 ml saline, i.v.) was given when necessary. Temperature was maintained at 37 + 0.5"C with a hot-water heating pad beneath the rat. End-tidal CO, was monitored with a capnometer (model 2200, International Medical Inc., Bumsville, MN) and maintained between 3.5% and 4.5% throughout the experiment by small adjustments in the rate (58-65 breathslmin) and volume (1.8-2.2 ml) of respiration. Laminectomies exposed both the lumbar (for recording) and the cervical (for antidromic activation of lumbar neurons projecting rostrally) enlargements of the spinal cord. The head and vertebral column of the animal were mounted on a rigid frame in a Faraday cage. Tungsten microelectrodes (1 MR) glued to 7-barreled borosilicate-glass microelectrodes were used to record from single spinal neurons and to apply drugs iontophoretically.
An analog window discriminator was used to detect action potentials that were at least two times larger than noise or spikes from other neurons. Antidromic activation was used at least once every 5 min and during most epochs of inhibition of orthodromic activity to verify constant spike shape and amplitude.
The cells were located at indicated depths between 100 and 700 pm from the dorsal surface, and histological verification of cell location in dorsal horn was possible in seven cases. Once a projection neuron was located by antidromic activation from the cervical spinal cord, the neuron's cutaneous receptive field was characterized by mechanical stim- ulation (brush, pressure, pinch, and squeeze). Cells were classified as follows: (1) low-threshold (LT) cells responded best to either brush or pressure; (2) wide-dynamic-range (WDR) cells responded in a graded manner to brush, pressure, pinch, and squeeze; (3) high-threshold (HT) cells responded best to either pinch or squeeze, with little or no response to brush or pressure. WDR and HT neurons are termed nociceptive.
Action potentials of the neurons evoked by iontophoretic application of excitatory and inhibitory agents and by natural stimulation of the cutaneous receptive field were collected and stored as peristimulus-time histograms ( 1 -set binwidth) of firing rate using a microcomputer (Aanonsen et al., 1990) . The following drugs were used: NMDA (NMDA receptor agonist); AMPA [AMPA receptor (or quisqualate-gated cation channel) agonist]; 2-methyl serotonin (5-HT, receptor agonist); zacopride (5-HT, antagonist); muscimol and bicuculline (GABA, agonist and antagonist, respectively). Older nomenclature refers to the AMPA receptor as the quisqualate receptor, but possible confusion with the G-protein-coupled quisqualate receptor mandates this new nomenclature (Watkins et al., 1990) . Drugs (5-20 mM) were dissolved in NaCl solution. Sufficient NaCl was added so that the total ionic strength of the solution was 200 mM. NMDA and AMPA solutions were adjusted to pH 8.0, retained with positive current (a2 nA), and ejected with negative current (2-l 20 nA); 2-methyl serotonin, zacopride, bicuculline, and muscimol solutions were adjusted to pH 4, retained with negative current (4-10 nA), and ejected with positive current (5-60 nA). NMDA and AMPA were applied regularly and repeatedly in brief pulses. 2-Methyl serotonin, muscimol, bicuculline, and zacopride were ejected with various currents superimposed on repeated NMDA or AMPA pulses.
Our determination of inhibition of firing is based on a reduction of total spikes elicited per excitant epoch (i.e., area under the curve). Stable baseline response rates to NMDA or AMPA were obtained (variability, ~20%) before other drugs were applied. Inhibition is reported for reductions of the area under the curve of 40% or more. We felt justified in selecting this artificial cutoff value instead of applying a statistical test for three reasons: (1) examination of several hundred epochs of unit activity indicated that responses of a stable preparation never decreased this much spontaneously, (2) our use of area under the curve instead of peak firing rate is itself a statistical summary that takes account of some natural variability, and (3) the validity of most standard statistical tests, such as ANOVA or t tests that we might have used, relies on sample independence that is not clearly met by successive recordings from a single neuron. We defined complete blockade of an inhibitory effect as a return of responses to 100% of control levels, and partial blockade as a return of responses to 80% of control levels. nmol/mouse, i.t.; data not shown) effectively antagonized 2-methyl 5-HT-induced antinociception. These results in mice confirm those obtained by others in rats (Glaum et al., 1989 (Glaum et al., , 1990 . The antinociceptive effect of 2-methyl 5-HT was also blocked or reduced by the GABA antagonists (Fig. 1B) bicuculline and picrotoxin (GABA, antagonists) and phaclofen (GA-BA, antagonist). At doses that had no effect by themselves, bicuculline (0.02 nmol/mouse, i.t.) or picrotoxin (0.04 nmol/ mouse, i.t.) completely blocked the antinociceptive effect of 2-methyl 5-HT, while phaclofen (4 nmol/mouse, i.t.) only partially blocked it. These antagonist effects were significant overall (F3,27 = 34.9; p < 0.00 1; ANOVA) as well as by individual group post hoc tests. Naloxone (0.3 nmol/mouse, a dose that antagonizes a 90% MPE morphine dose of 1 pg, i.t.) did not block the antinociceptive effect of 2-methyl 5-HT. 2-Methyl 5-HT (0.3-3.3 nmol/mouse) inhibited the biting and scratching behavior induced by both NMDA (0.25 nmol, i.t.) and SP (10 pmol, i.t.) in a dose-dependent manner (Fig. 2) . Whereas the NMDA-elicited behavior was completely blocked by 2-methyl5-HT(F,,,, = 82.0; p < 0.00 l), SP-elicited behavior was reduced by only 65% (F,,,, = 45.7; p < 0.001). Zacopride (0.3-l .O nmol/mouse) blocked the actions of 2-methyl5-HT on both SP-(F4,28 = 36.0; p < 0.001) and NMDA-induced (F3,28 = 79.2; p < 0.001) behaviors ( Fig. 2A,B, insets) . Zacopride by itself, at doses below 10 nmol, produced no overt behavioral effects, but at doses over 10 nmol, it induced behavior similar to that induced by NMDA, this result suggests that the effect of some tonic 5-HT release was being removed. In the case of NMDA-induced behavior, the effect of 2-methyl5-HT was also blocked by bicuculline (Fig. 2,4 Twenty-two spinal cord projection neurons (LT. 2; WDR. 12; HT. 8) were identified in I2 rats. This study was conducted as part of a larger study of I I I spinal projection neurons (Lei and Wilcox, unpublished observations) ; the responses to natural stimulation, NMDA, and AMPA reported here are typical of the responses to be reported in that larger study. The responses are also consistent with those reported in a previous study from this laboratory; that study showed that nociceptive neurons consistently respond to iontophoretically applied NMDA (Aanonsen et al., 1990) . All 22 neurons examined in the present study responded to either NMDA or AMPA. 20 were nociceptive. and I2 responded to both agents. The responses to NMDA and AMPA had short onset latency (< 5 set) and duration (< 5 set after termination). All neurons also responded to cutaneous stimulation of the ipsilateral hindpaw and to antidromic activation from lateral upper cervical white matter. 2-Methyl S-HT inhibited in a current-related manner NMDAinduced excitation in all 20 neurons excited by NMDA (Fig. 3) . The inhibitory effect of 2-methyl 5-HT was blocked by zacopride in all six cells tested (Fig. 3A) ; zacopride alone usually increased NMDA-elicited firing as shown in Figure 3A . which is consistent with the behavioral data and suggests the presence of tonic serotonergic activity in these rats. 2-Methyl 5-HT inhibited AMPA-induced excitation less frequently (9 of 14; Fig.  4B ) than NMDA-induced excitation (20 of 20; Fig. 4A ). An example of one neuron excited by both excitants is shown in Figure 4 , .4 and B. In 5 of6 neurons where the two EAA agonists were compared for susceptibility to 2-methyl 5-HT. NMDAelicited firing was more sensitive to inhibition by 2-methyl5-HT than that ofAMPA [data, expressed as (% inhibition ofNMDA)/ (96 inhibition of AMPA), for the five neurons for which NMDA activation was more susceptible: 75/26, 77/59. 86149, 84/68, and 40130; for the sixth neuron, 571901. Muscimol similarly . In all six neurons tested, bicuculline reduced the inhibitory effect of 2-methyl 5-HT on NMDA-elicited excitation. in four completely and two partially (Fig. 40) . In summary, nociceptive projection neurons were always inhibited (never excited) by 2-methyl 5-HT, and these inhibitory effects were blocked by either GABA, or 5-HT, antagonists.
Results

Behavior
Discussion
To our knowledge, these results represent the first combined behavioral and electrophysiological examination of the role of the 5-HT, receptor subtype in 5-HT's spinal antinociceptive action. We confirmed earlier studies showing that activation of 5-HT, receptors produces thermal antinociception and extended these results to encompass other behavioral tests in another species and electrophysiological measures of sensory neural activity. Our finding of serotonergic inhibition of EAA-induced firing (EAAs are generally thought to act postsynaptically) together with the recordings of IPSPs after activation ofa putative serotonergic pathway (Giesler et al., 198 I) suggests a postsynaptic site of action in the spinal cord dorsal horn. That this action could be prevented by GABA,, GABA,, or 5-HT, antagonists indicates the participation of these receptor subtypes in production of this antinociception. Consistency between behavioral and electrophysiological studies diminishes the possibility that drug-induced motor effects are responsible for our behavioral observations. The results of the current study are consistent with the idea that 2-methyl5-HT releases GABA and are in agreement with the differential involvement ofthe GABA receptor subtypes in two behavioral tests. Because 5-HT, receptors are ligand-gated cation channels, it is unlikely that they exert a direct inhibitory action in the CNS.
The Journal of Neuroscience, July 1991, 11 (7) Ejection Current (nA) Therefore, the inhibition we observed following activation of these receptors is probably due to excitation of an inhibitory neuron. Our finding that GABA antagonists block the action of SHT, agonists in the spinal cord suggests that endogenously released 5-HT in the cord excites a neuron, which then releases GABA. We have diagrammed schematically how activation of SHT-containing descending tracts might release spinal GABA and how this GABA might inhibit nociceptive projection neurons in Figure 5 ; this tentative diagram, though not directly supported by the data, could account for both the behavioral and electrophysiological observations reported here. GABAergic interneurons in substantia gelatinosa (Hayes and Carlton, 1990 ) may be too small to be sampled by our relatively large recording electrode array. Indeed, a previous study using electrodes optimized to record from smaller interneurons found that 5-HT excited a preponderance of neurons in substantia gelatinosa (Todd and Millar, 1983) . Previous studies have reported that GABA, antagonists do not reverse inhibition of spinal neurons elicited by NRM stimulation (Belcher et al., 1978; Griersmith et al., 198 1) . However, use in that study of nonselective EAA agonists and natural stimulation may account for this negative finding: if activation by the EAA agonists or by the synaptically released glutamate involved AMPA receptors, we would not expect synaptically released 5-HT to inhibit the activation completely. Alternatively, the NRM stimulation parameters used may have recruited nonserotonergic descending pathways. We attribute the consistency of our results to (1) our use of 2-methyl5-HT, which selectively activates 5-HT, receptors; (2) our use of selective agonists for EAA receptors as excitants (Aanonsen et al., 1990) ; and (3) our selection of projection neurons. Whereas 5-HT activates all 5-HT receptor subtypes and produces pro-as well as antinociceptive effects in behavioral tests, 2-methyl5-HT activates one subtype selectively and produces only antinociceptive effects when injected intrathecally in mice . Although the selectivity of 2-methyl5-HT for 5-HT, receptors is not absolute, its selectivity for 5-HT, over 5-HT, receptors in some assays approaches 1000: 1 (Richardson et al., 1985) . Our failure to see any evidence of scratching behavior, which seems to be mediated by 5-HT, receptors ), even at high intrathecal fields for each neuron. Time (set) doses of 2-methyl5-HT supports our contention that 2-methyl 5-HT is acting selectively at 5-HT, receptors in the rodent spinal cord. The apparently pronociceptive action of high doses of zacopride (NMDA-like biting and scratching behavior) may result from disinhibition of neurons that are under the inhibitory influence of tonically released 5-HT. Although we have not excluded the possibility that zacopride activates 5-HT, receptors as an agonist to produce such behavior, we think this unlikely because zacopride-induced behavior appeared qualitatively more like NMDA-elicited behavior than like behavior elicited by a-methyl 5-HT (a 5-HT, agonist; Wilcox and Alhaider, 1990) .
The effects of 2-methyl 5-HT in the tail-flick test were completely blocked by zacopride and the GABA, antagonists bicuculline and picrotoxin, only partially blocked by the GABA, 0 antagonist phaclofen, and not blocked at all by the opioid antagonist naloxone. It appears, therefore, that tail-flick antinociception produced by 2-methyl 5-HT relies more on GABA, than GABA, receptors, and that opioid receptors are not involved. Bicuculline also blocked the inhibitory effect of 2-methyl 5-HT on NMDA-induced behavior ( Fig. 2A, inset) , whereas phaclofen was ineffective. In contrast, phaclofen blocked the inhibitory effect of 2-methyl5-HT on SP-induced behavior (Fig.  2B, inset) , while bicuculline was inactive. We have previously found that NMDA-induced behavior can be blocked by GABA, (but not GABA,) agonists (Aanonsen and Wilcox, 1989) , while SP-induced behavior can be blocked by GABA, (but not GA-BA,) agonists (Hwang and Wilcox, 1989) . We therefore conclude from the behavioral studies with GABA antagonists that Raphe-Spinal Cutaneous I on Figure 5 . A hypothetical neuronal arrangement that accounts for our experimental findings. Raphe-spinal neurons (e.g., in NRM) presumably release 5-HT in the spinal cord, and the released 5-HT activates 5-HT, receptors on GABAergic interneurons. GABA released by these intemeurons acts postsynaptically to inhibit nociceptive projection neurons; in the case of NMDA-mediated activation, GABA, receptors appear to be most effective. Both the behavioral and the electrophysioloeical data reoorted here support the synaptic arrangement around the-spinal projection neuron. 'ihe raphgspinal connection shown is based on the work of others (Belcher et al., 1978; Giesler et al., 198 1; Griersmith et al., 198 l) , and the selective association between GABA, and SP receptors suggested by our behavioral data is not diagrammed.
2-methyl5-HT may facilitate the release of GABA; the released GABA then inhibits NMDAand SP-induced behavior at GA-BA, and GABA, receptors, respectively. The 5-HT, receptor may represent an important mediator of the descending serotonergic control of nociceptive transmission through the dorsal horn, particularly that component of afferent excitatory transmission mediated through NMDA receptors. We have found that NMDA receptors are important in nociceptive neurotransmission in the dorsal horn (Aanonsen et al., 1990) , and others have recently found that this NMDA component may mediate "wind-up" phenomena elicited by repeated stimulation (Mendell, 1966; Davies and Lodge, 1987; Thompson et al., 1990) . This wind-up phenomenon may contribute to strong pain sensations in humans (Jorum et al., 1990) . We have found that this component of the afferent nociceptive message is particularly susceptible to p-opioid agonists (Aanonsen and Wilcox, 1987; Lei and Wilcox, 1989) ; it is well accepted that agents in this class are the most effective and addicting analgesics (Jaffe, 1985 
